CIK 0001640266
- Accelerated filer
- Smaller reporting company
Voyager Therapeutics, Inc.
Sign in to watch- Ticker
- VYGR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-259-5340
- Business address
- 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 72 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-01 | Swartz Robin President | Grant or award | +68,250 | 267,988 | ||
| 2026-11-01 | Swartz Robin President | Grant or award · Stock Option (Right to Buy) | +318,500 | 318,500 | ||
| 2026-02-24 | Swartz Robin COO & CBO | Sale 10b5-1 | −6,458 | $3.77 | $24K | 199,738 |
| 2026-02-18 | Swartz Robin COO & CBO | Sale 10b5-1 | −3,882 | $3.44 | $13K | 206,196 |
| 2026-02-10 | Swartz Robin COO & CBO | Sale | −4,569 | $3.85 | $18K | 210,078 |
| 2026-02-06 | Swartz Robin COO & CBO | Grant or award | +45,000 | 214,647 | ||
| 2026-02-06 | Swartz Robin COO & CBO | Grant or award · Stock Option (Right to Buy) | +210,000 | 210,000 | ||
| 2025-02-21 | Swartz Robin COO & CBO | Grant or award | +71,250 | 169,647 | ||
| 2025-02-21 | Swartz Robin COO & CBO | Grant or award · Stock Option (Right to Buy) | +142,500 | 142,500 | ||
| 2025-02-20 | Swartz Robin COO & CBO | Sale | −3,894 | $4.25 | $17K | 98,397 |
| 2025-02-11 | Swartz Robin COO & CBO | Sale | −6,950 | $4.45 | $31K | 102,291 |
| 2025-01-14 | Swartz Robin COO & CBO | Sale | −3,087 | $5.09 | $16K | 109,241 |
| 2024-12-23 | Swartz Robin COO&CBO | Sale | −6,500 | $5.65 | $37K | 112,328 |
| 2024-04-02 | Swartz Robin Chief Operating Officer | Sale | −1,357 | $9.88 | $13K | 117,004 |
| 2024-02-21 | Swartz Robin Chief Operating Officer | Sale | −3,966 | $7.45 | $30K | 118,361 |
| 2024-02-09 | Swartz Robin Chief Operating Officer | Grant or award | +50,000 | 122,327 | ||
| 2024-02-09 | Swartz Robin Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-01-17 | Swartz Robin Chief Operating Officer | Sale | −2,543 | $7.15 | $18K | 72,327 |
| 2023-04-03 | Swartz Robin Chief Operating Officer | Sale | −1,259 | $7.83 | $10K | 71,617 |
| 2023-03-20 | Swartz Robin Chief Operating Officer | Sale | −3,654 | $7.76 | $28K | 72,876 |
Page 1 of 2 · 29 trades